Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Leptomycin B enhances CDDP-sensitivity via nuclear accumulation of p53 protein in HPV-positive cells.

Naniwa J, Kigawa J, Akeshima R, Kanamori Y, Itamochi H, Oishi T, Iba T, Terakawa N.

Cancer Sci. 2003 Dec;94(12):1099-103.

2.

Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary.

Itamochi H, Kigawa J, Akeshima R, Sato S, Kamazawa S, Takahashi M, Kanamori Y, Suzuki M, Ohwada M, Terakawa N.

Oncology. 2002;62(4):349-53.

PMID:
12138243
3.

Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.

Itamochi H, Kigawa J, Sultana H, Iba T, Akeshima R, Kamazawa S, Kanamori Y, Terakawa N.

Jpn J Cancer Res. 2002 Jun;93(6):723-8.

4.

Timing of G-CSF administration based on the circadian rhythm in patients with ovarian cancer.

Sato S, Kigawa J, Irie T, Itamochi H, Kanamori Y, Kamazawa S, Akeshima R, Terakawa N.

Am J Clin Oncol. 2002 Jun;25(3):289-90.

PMID:
12040291
5.

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.

Akeshima R, Kigawa J, Takahashi M, Oishi T, Kanamori Y, Itamochi H, Shimada M, Kamazawa S, Sato S, Terakawa N.

Br J Cancer. 2001 Jun 1;84(11):1551-5.

6.

Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.

Kanamori Y, Kigawa J, Itamochi H, Shimada M, Takahashi M, Kamazawa S, Sato S, Akeshima R, Terakawa N.

Clin Cancer Res. 2001 Apr;7(4):892-5.

7.

Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells.

Kamazawa S, Kigawa J, Minagawa Y, Itamochi H, Shimada M, Takahashi M, Sato S, Akeshima R, Terakawa N.

Oncology. 2000 Nov;59(4):329-35.

PMID:
11096346
8.

Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.

Irie T, Kigawa J, Minagawa Y, Itamochi H, Sato S, Akeshima R, Terakawa N.

Eur J Surg Oncol. 2000 Aug;26(5):464-7.

PMID:
11016467
9.

Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells.

Takahashi M, Kigawa J, Minagawa Y, Itamochi H, Shimada M, Kamazawa S, Sato S, Akeshima R, Terakawa N.

Eur J Cancer. 2000 Sep;36(14):1863-8.

PMID:
10974635
10.

Alteration of telomerase activity in ovarian cancer after chemotherapy.

Takahashi M, Kigawa J, Oishi T, Itamochi H, Shimada M, Sato S, Kamazawa S, Akeshima R, Terakawa N.

Gynecol Obstet Invest. 2000;49(3):204-8.

PMID:
10729763

Supplemental Content

Loading ...
Support Center